Chemed Stock Jumps 11% on Q1 Beat, VITAS Hospice Strength and Raised 2026 Outlook

Fuente: International Business Times

Pixabay Chemed Corp. shares soared more than 10% in midday trading Friday, climbing to around $424 after the healthcare services company delivered a solid first-quarter 2026 earnings beat, highlighted by strong performance at its VITAS hospice business and an upgraded full-year outlook that exceeded Wall Street expectations. The stock (NYSE: CHE) opened sharply higher and sustained robust gains on April 24, with trading volume well above average.